CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 12, 2011, Pages 2008-2016

  Yoon, Haejin ^a   Lim, Ji Hong ^a   Cho, Chung Hyun ^a   Huang, L Eric ^b   Park, Jong Wan ^a  

^a Seoul National University College of Medicine   (South Korea)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

CBP p300 interacting transactivator with an ED rich tail 2; Hypoxia inducible factor 1 ; P300; Transactivation domains; Von Hippel Lindau protein

Indexed keywords

CBP P300 INTERACTING TRANSACTIVATOR WITH AN ED RICH TAIL 2; CYSTEINE; HISTIDINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P300; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN INTERACTION; TRANSACTIVATION;

ANOXIA; BLOTTING, WESTERN; CELLS, CULTURED; E1A-ASSOCIATED P300 PROTEIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; KIDNEY; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 80053371042     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.08.018     Document Type: Article

References (31)

1. Wenger R.H. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 2002, 16:1151-1162.
2. Mole D.R., Ratcliffe P.J. Cellular oxygen sensing in health and disease. Pediatr. Nephrol. 2008, 23:681-694.
3. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 2001, 7:345-350.
4. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:5510-5514.
5. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Kaelin W.G. HIF-alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464-468.
6. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A.v., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
7. Freedman S.J., Sun Z.Y., Poy F., Kung A.L., Livingston D.M., Wagner G., Eck M.J. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:5367-5372.
8. Dayan F., Roux D., Brahimi-Horn M.C., Pouyssegur J., Mazure N.M. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res. 2006, 66:3688-3698.
9. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996, 384:641-643.
10. Bhattacharya S., Ratcliffe P.J. ExCITED about HIF. Nat. Struct. Biol. 2003, 10:501-503.
11. Ruas J.L., Berchner-Pfannschmidt U., Malik S., Gradin K., Fandrey J., Roeder R.G., Pereira T., Poellinger L. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300. J. Biol. Chem. 2010, 285:2601-2609.
12. Bhattacharya S., Michels C.L., Leung M.K., Arany Z.P., Kung A.L., Livingston D.M. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 1999, 13:64-75.
13. Bragança J., Eloranta J.J., Bamforth S.D., Ibbitt J.C., Hurst H.C., Bhattacharya S. Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J. Biol. Chem. 2003, 278:16021-16029.
14. Freedman S.J., Sun Z.Y., Kung A.L., France D.S., Wagner G., Eck M.J. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat. Struct. Biol. 2003, 10:504-512.
15. Chun Y.S., Choi E., Kim G.T., Lee M.J., Lee M.J., Lee S.E., Kim M.S., Park J.W. Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1alpha, but inhibits the nuclear translocation of HIF-1beta, causing HIF-1 inactivation. Biochem. Biophys. Res. Commun. 2000, 268:652-656.
16. To K.K., Huang L.E. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1. J. Biol. Chem. 2005, 280:38102-38107.
17. Shin D.H., Li S.H., Chun Y.S., Huang L.E., Kim M.S., Park J.W. CITED2 mediates the paradoxical responses of HIF-1α to proteasome inhibition. Oncogene 2008, 27:1939-1944.
18. Ruas J.L., Poellinger L., Pereira T. Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation and/or interaction with CREB-binding protein. J. Biol. Chem. 2002, 277:38723-38730.
19. Blobel G.A. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 2000, 95:745-753.
20. Kasper L.H., Lerach S., Wang J., Wu S., Jeevan T., Brindle P.K. CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. EMBO J. 2010, 29:3660-3672.
21. Vo N., Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 2001, 276:13505-13508.
22. Yang C., Shapiro L.H., Rivera M., Kumar A., Brindle P.K. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol. Cell. Biol. 1998, 18:2218-2229.
23. Jayaraman G., Srinivas R., Duggan C., Ferreira E., Swaminathan S., Somasundaram K., Williams J., Hauser C., Kurkinen M., Dhar R., Weitzman S., Buttice G., Thimmapaya B. p300/CAMP-responsive element-binding protein interactions with Ets-1 and Ets-2 in the transcriptional activation of the human stromelysin promoter. J. Biol. Chem. 1999, 274:17342-17352.
24. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002, 16:1466-1471.
25. Kung A.L., Wang S., Klco J.M., Kaelin W.G., Livingston D.M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 2000, 6:1335-1340.
26. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
27. Lu X., Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res. 2010, 16:5928-5935.
28. Kerbel R., Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2002, 2:727-739.
29. Birle D.C., Hedley D.W. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors. Cancer Res. 2007, 67:1735-1743.
30. Bai L., Merchant J.L. A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Lett. 2007, 581:5904-5910.
31. Lau W.M., Weber K.L., Doucet M., Chou Y.T., Brady K., Kowalski J., Tsai H.L., Yang J., Kominsky S.L. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2. Int. J. Cancer 2010, 126:876-884.